These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression. Rak J; Klement P; Yu J Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463 [TBL] [Abstract][Full Text] [Related]
14. Thrombin generation and the pathogenesis of cancer. Ruf W; Mueller BM Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():61-8. PubMed ID: 16673267 [TBL] [Abstract][Full Text] [Related]
15. Tissue factor in cancer progression and angiogenesis. Ruf W; Yokota N; Schaffner F Thromb Res; 2010 Apr; 125 Suppl 2(0 2):S36-8. PubMed ID: 20434002 [TBL] [Abstract][Full Text] [Related]
16. Pathogenesis, clinical and laboratory aspects of thrombosis in cancer. Franchini M; Montagnana M; Targher G; Manzato F; Lippi G J Thromb Thrombolysis; 2007 Aug; 24(1):29-38. PubMed ID: 17396228 [TBL] [Abstract][Full Text] [Related]
17. Crosstalk between cancer and haemostasis. Implications for cancer biology and cancer-associated thrombosis with focus on tissue factor. Langer F; Bokemeyer C Hamostaseologie; 2012; 32(2):95-104. PubMed ID: 21792469 [TBL] [Abstract][Full Text] [Related]
18. Inflammation, obesity, and thrombosis. Samad F; Ruf W Blood; 2013 Nov; 122(20):3415-22. PubMed ID: 24092932 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-2: A key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling. Das K; Prasad R; Ansari SA; Roy A; Mukherjee A; Sen P Biomed Pharmacother; 2018 Sep; 105():395-406. PubMed ID: 29870887 [TBL] [Abstract][Full Text] [Related]